HIV-associated Kaposi sarcoma: pathogenic mechanisms

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 104, Issue 4, 2007, Pages 521-529

  Feller, Liviu ^a   Wood, Neil H ^a   Lemmer, Johan ^a  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; G PROTEIN COUPLED RECEPTOR, HUMAN HERPESVIRUS 8; G PROTEIN-COUPLED RECEPTOR, HUMAN HERPESVIRUS 8; GROWTH PROMOTOR; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; KAPOSI SARCOMA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINES; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CHEMOKINE; SARCOMA, KAPOSI;

EID: 34648825062     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2006.08.015     Document Type: Article

References (124)

1. Tappero J.W., Conant M.A., Wolfe S.F., and Berger T.G. Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 28 (1993) 371-395
2. Delabesse E., Oksenhendler E., Lebbé C., Vérola O., Varet B., and Turhan A.G. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol 50 (1997) 664-668
3. Sodhi A., Montaner S., Patel V., Zohar M., Bais C., Mesri E.A., et al. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor upregulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res 60 (2000) 4873-4880
4. Yang T.Y., Chen S.C., Leach M.W., Manfra D., Homey B., Wiekowski M., et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191 (2000) 445-453
5. Montaner S., Sodhi A., Pece S., Mesri E.A., and Gutkind J.S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/Protein Kinase B. Cancer Res 61 (2001) 2641-2648
6. Guo H.G., Sadowska M., Reid W., Tschachler E., Hayward G., and Reitz M. Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF 74 transgenic mouse. J Virol 77 (2003) 2631-2639
7. Friedman-Kien A.E., and Saltzman B.R. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 22 (1990) 1237-1250
8. Schwartz R.A. Kaposi's sarcoma: advances and perspectives. J Am Acad Dermatol 34 (1996) 804-814
9. Antman K., and Chang Y. Kaposi's sarcoma. N Engl J Med 342 (2000) 1027-1038
10. Iscovich J., Boffetta P., Franceschi S., Azizi E., and Sarid R. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer 88 (2000) 500-517
11. Hengge U.R., Ruzicka T., Tyring S.K., Stuschke M., Roggendorf M., Schwartz R.A., et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations and therapy. Lancet Infect Dis 2 (2002) 281-292
12. Hengge U.R., Ruzicka T., Tyring S.K., Stuschke M., Roggendorf M., Schwartz R.A., et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: Pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2 (2002) 344-352
13. Schwartz R.A. Kaposi's sarcoma: an update. J Surg Oncol 87 (2004) 146-151
14. Cesarman E., Chang Y., Moore P.S., Said J.W., and Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity B-cell lymphomas. N Engl J Med 332 (1995) 1186-1191
15. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., et al. Kaposi's sarcoma associated herpesvirus-like DNA sequences in multicentric Castleman's Disease. Blood 86 (1995) 1276-1280
16. Dupin N., Diss T.L., Kellam P., Tulliez M., Du M.Q., Sicard D., et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8 positive plasmablastic lymphoma. Blood 95 (2000) 1406-1412
17. Du M.O., Liu H., Diss T.C., Ye H., Hamoudi R.A., Dupin N., et al. Kaposi's sarcoma-associated herpesvirus infects monotypic (IGMλ) but polyclonal naïve B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97 (2001) 2130-2136
18. Ho H.H., Ganeshalingam N., Rosenhouse-Dantsker A., Osman R., and Gershengorn M.C. Charged residues at the intracellular boundary of transmembrane helices 2 and 3 independently affect constitutive activity of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Biol Chem 276 (2001) 1376-1382
19. Ablashi D.V., Chatlynne L.G., Whitman Jr. J.E., and Cesarman E. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbial Rev 15 (2002) 439-464
20. Cioc A.M., Allen C., Kalmar J.R., Suster S., Baiocchi R., and Nuovo G.J. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 28 (2004) 41-46
21. Montaner S., Sodhi A., Servitja J.M., Ramsdell A.K., Barac A., Sawai E.T., et al. The small GTPase Rac 1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Blood 104 (2004) 2903-2911
22. Epstein J.B., Cabay R.J., and Glick M. Oral malignancies in HIV disease: changes in disease presentation, increasing understanding of molecular pathogenesis, and current management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 (2005) 571-578
23. Frezzini C., Leao J.C., and Porter S. Current trends of HIV disease of the mouth. J Oral Pathol Med 34 (2005) 513-531
24. Moore P.S., and Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 332 (1995) 1181-1185
25. Hille J.J., Webster-Cyriaque J., Palefski J.M., and Raab-Traub N. Mechanism of expression of HHV-8, EBV and HPV in selected HIV-associated oral lesions. Oral Dis 8 suppl 2 (2002) 161-168
26. Teo C.G. Viral infections in the mouth. Oral Dis 8 suppl.2 (2002) 88-90
27. Webster-Cyriaque J. Development of Kaposi's sarcoma in a surgical wound. N Engl J Med 346 (2002) 1207-1209
28. Lager I., Altini M., Coleman H., and Ali H. Oral Kaposi's sarcoma: a clinico-pathologic study from South Africa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 701-710
29. kB and induces p6 inflammatory cytokine and chemokine production via a c-terminal signaling determinant. J Immunol 167 (2001) 505-513
30. Feller L., Jadwat Y., and Raubenheimer E.J. Kaposi's sarcoma and calcium channel blocker-induced gingival enlargement occurring simultaneously: review of the literature and report of a case. Oral Biosciences and Medicine 4 (2004) 291-297
31. Sodhi A., Montaner S., Patel V., Gomez-Roman J.J., Li Y., Sausville E.A., et al. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptors. Proc Natl Acad Sci U S A 101 (2004) 4821-4826
32. Boshoff C., Whitby D., Talbot S., and Wseiss R.A. Etiology of AIDS-related Kaposi's sarcoma and lymphoma. Oral Dis 3 suppl 1 (1997) S129-S132
33. Fauci A.S., and Lane H.C. Human immunodeficiency virus disease: AIDs and related disorders. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 1076-1139
34. Zakrzewska J.M. Overvies: Kaposi's sarcoma, oral neoplasms. Oral Dis 3 suppl 1 (1997) S122-S123
35. Bower M., Nelson M., Young A.M., Thirlwell C., Newsom-Davis T., Mandalia S., et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 23 (2005) 5224-5228
36. Leidner R.S., and Aboulafia D.M. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 19 (2005) 635-644
37. Reichart P.A., Langford-Kuntz A., and Pohle H.D. Epidemic oro-facial Kaposi's sarcoma (EKS)-report of 124 cases. Oral Oncol Eur J Cancer 27 (1993) 187-189
38. Flaitz C.M., Jin Y.T., Hicks M.J., Nichols M., Wang Y.W., and Su I.O. Kaposi's sarcoma associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma. A PCR and clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 (1997) 259-264
39. Kalpidis C.D.R., Lysitsa S.N., Lombardi T., Kolokotronis A.E., Antoniades D.Z., and Samson J. Gingival involvement in a case series of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. J Periodontol 77 (2006) 523-533
40. Ficarra G., Berson A.M., Silverman Jr. S., Quivey J.M., Lozada-Nur F., Sooy D.D., et al. Kaposi's sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects and treatment. Oral Surg Oral Med Oral Pathol 66 (1988) 543-550
41. Epstein J.B. Management of oral Kaposi's sarcoma and a proposal for clinical staging. Oral Dis 3 suppl 1 (1997) S124-S128
42. Lausten L.L., Ferguson B.L., Barker B.F., and Cobb C.M. Oral Kaposi's sarcoma associated with severe alveolar bone loss: case report and review of the literature. J Periodontol 74 (2003) 1668-1675
43. Reichart P.A., KhongKhunthian P., and Bendick C. Oral manifestations in HIV-infected individuals from Thailand and Cambodia. Med Microbiol Immunol 192 (2003) 157-160
44. Langford A., Phole H.D., and Reichart P. Primary intraosseous AIDS-associated Kaposi's sarcoma. Report of two cases with initial jaw involvement. Int J Oral Maxfac Surg 20 (1991) 366-368
45. Nichols C.M., Flaitz C.M., and Hicks M.J. Primary intraosseous Kaposi's sarcoma of the maxilla in human immunodeficiency virus infection: review of the literature and report of a case. J Oral Maxillofac Surg 53 (1995) 325-329
46. Pauk J., Huang M.L., Brodie S.J., Wald A., Koelle D.M., Schacker T., et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 343 (2000) 1369-1377
47. Cannon M.J., Dollard S.C., Black J.B., Edlin B.R., Hannah C., Hogan S.E., et al. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS 17 (2003) 215-222
48. Taylor M.M., Chohan B., Lavreys L., Hassan W., Huang M.L., Corey L., et al. Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1 seropositive and seronegative Kenyan women. J Infec Dis 190 (2004) 484-488
49. Rohrmus B., Thoma-Greber E.M., Rocken M., and Bogner J.R. Outlook in oral and cutaneous Kaposi's sarcoma. Lancet 356 (2000) 2160
50. Ablashi D., Chatlynne L., Cooper H., Thomas D., Yadav M., Norhanom A.W., et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the United States, the Caribbean and Africa. Br J Cancer 81 (1999) 893-897
51. Chatlynne L.G., Lapps W., Handy M., Huang Y.O., Masood R., Hamilton A.S., et al. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 92 (1998) 53-58
52. Gambus G., Bourboulia D., Esteve A., Lahoz R., Rodriguez C., Bolao F., et al. Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS 15 (2001) 1167-1174
53. Juhasz A., Remenyik E., Konya J., Veress G., Begany A., Andriko I., et al. Prevalence and age distribution of human herpesvirus-8 specific antibodies in Hungarian blood donors. J Med Virol 64 (2001) 526-530
54. Preiser W., Szep N.I., Lang D., Doerr H.W., and Rabenau H.F. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected German patients: evaluation by different test system. Med Microbiol Immunol (Berl) 190 (2001) 121-127
55. Whitby D., Luppi M., Barozzi P., Boshoff C., Weiss R.A., and Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 90 (1998) 395-397
56. Olsen S.J., Chang Y., Moore P.S., Biggar R.J., and Melbye M. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 12 (1998) 1921-1925
57. Engels E.A., Sinclair M.D., Biggar R.J., Whitby D., Ebbesen P., Goedert J.J., et al. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta. Int J Cancer 88 (2000) 1003-1008
58. Whitby D., Marshall V.A., Bagni R.K., Wang C.D., Gamache C.J., Guzman J.R., et al. Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J Gen Virol 85 (2004) 155-163
59. Lennette E.T., Blackbourne D.J., and Levy J.A. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348 (1996) 858-861
60. de-The G., Bestetti G., Van Beveren M., and Gessain A. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa. J Natl Cancer Inst 91 (1999) 1888-1889
61. Grossman Z., Iscovich V., Schwartz F., Azizi E., Klepfish A., Schattner A., et al. Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. Mayo Clin Proc 77 (2002) 905-909
62. Ziegler J.L., Newton R., Katongole-Mbidde E., Mbulataiye S., De Cock K., Wabinga H., et al. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS 11 (1997) 1619-1626
63. Wabinga H.R., Parkin D.M., Wabwire-Mangen F., and Manbooze S. Trends in cancer incidence in Kyadono country, Uganda, 1960-1997. Br J Cancer 82 (2000) 1585-1592
64. Martin J.N., Ganem D.E., Osmond D.H., Page-Shafer K.A., Macrae D., and Kedes D.H. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338 (1998) 948-954
65. O'Brien T.R., Kedes D., Ganem D., Macrae D.R., Rosenberg P.S., Molden J., et al. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors and relationship to Kaposi's sarcoma. J Infect Dis 180 (1999) 1010-1017
66. Atkinson J., Eldin B.R., Engels E.A., Kral A.H., Seal K., Gamache C.J., et al. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis 187 (2003) 974-981
67. Gao S.J., Kingsley L., Li M., Zheng W., Parravicni C., Ziegler J., et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2 (1996) 925-928
68. Regamey N., Cathomas G., Schwager M., Wernli M., Harr T., and Erb P. High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol 36 (1998) 1784-1786
69. Whitby D., Howard M.R., Tenant-Flowers M., Brink N.S., Copas A., Boshoff C., et al. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346 (1995) 799-802
70. Moore P.S., Kingsley L.A., Holmberg S.D., Spira T., Gutpa P., Hoover D.R., et al. Kaposi's sarcoma-associated herpesvirus infection prior to the onset of Kaposi's sarcoma. AIDS 10 (1996) 175-180
71. Rezza G., Andreoni M., Dorrucci M., Pezzotti P., Monini P., Zerboni R., et al. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 91 (1999) 1468-1474
72. Jacobson L.P., Jenkins F.J., Springer G., Munos A., Shah K.V., Phair J., et al. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis 181 (2000) 1940-1949
73. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 (1994) 1865-1869
74. Buonaguro F.M., Tornesello M.L., Beth-Giraldo E., Hatzakis A., Muller N., Downing R., et al. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 65 (1996) 25-28
75. Huang Y.O., Li J.J., Zhang W.G., Feiner D., and Friedman-Kien A.E. Transcription of human herpesvirus-like agent (HHV-8) in Kaposi's sarcoma. J Clin Invest 97 (1996) 2803-2806
76. Kedes D., Operaiski E., Bush M., Khon R., Flood J., and Ganem D.E. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2 (1996) 918-924
77. Davis D.A., Humphrey R.W., Newcomb F.M., O'Brien T.R., Goedert J.J., Strauss S.E., et al. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide. J Infect Dis 175 (1997) 1071-1079
78. Means R.E., Choi J.K., Nakamura H., Chung Y.H., Ishido S., and Jung J.U. Immune evasion strategies of Kaposi's sarcoma-associated herpesvirus. Curr Top Microbiol Immunol 269 (2002) 187-201
79. Parravicini C., Olsen S.J., Capra M., Poli F., Sirchia G., Gao S.J., et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian post-transplant Kaposi's sarcoma patients. Blood 90 (1997) 2826-2829
80. Chatlynne L.G., and Ablashi D.V. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol 9 (1999) 175-185
81. Tsang P.C.S., and Samaranayake L.P. Oral manifestations of HIV infection in a group of predominantly ethnic Chinese. J Oral Pathol Med 28 (1999) 122-127
82. Anil S., and Challacombe S.J. Oral lesions of HIV and AIDS: an overview. Oral Dis 3 suppl 1 (1997) S36-S40
83. Nittayanata W., Jealae S., and Chung-panish S. Oral lesions in Thai heterosexual AIDS patients: a preliminary study. Br Dent J 182 (1997) 219-221
84. Lindtjorn B. Cancer in southern Ethiopia. J Trop Med Hyg 90 (1987) 752-758
85. Getachew A., Demissie M., and Gemechu T. Kaposi's sarcoma diagnosed in the Department of Pathology, Addis Ababa University Medical Faculty: a 15 years retrospective review of biopsy results 1981-1994. Ethiop Med J 35 (1997) 53-56
86. Figueroa J.I., Fuller L.C., Abraha A., and Hay R.J. Dermatology in south-western Ethiopia: rationale for a community approach. Int J Dermatol 37 (1998) 752-758
87. Kassa E., Rinke de Wit T.F., Hailu E., Girma M., Messele T., Mariam H.G., et al. Evaluation of the world Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS 13 (1999) 381-389
88. Cottoni F., and Montesu M.A. Kaposi sarcoma classification: a problem not yet defined. Int J Dermatol 35 (1996) 480-483
89. Naranatt P.P., Krishnan H.H., Svojanovsky S.R., Bloomer C., Mathur S., and Chandran B. Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res 64 (2004) 72-84
90. Rabkin C.S., Janz S., Lash A., Coleman A.E., Musaba E., Liotta L., et al. Monoclonal origin of multicentric Kasposi's sarcoma lesions. N Engl J Med 336 (1997) 988-993
91. Gill P.S., Tsai Y.C., Rao A.P., Spruck III C.H., Zheng T., Harrington Jr. W.A., et al. Evidence for multiconality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A 95 (1998) 8257-8261
92. Judde J.G., Lacoste V., Briere J., Kassa-Kelembho E., Clyti E., Couppie P., et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst 92 (2000) 729-736
93. Masood R., Cesarman E., Smith D.L., Gill P.S., and Flore O. Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Pathol 160 (2002) 23-29
94. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Keyl B.A., Dixit V., et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273 (1998) 30336-30343
95. Fujio Y., and Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependant manner. J Biol Chem 274 (1999) 16349-16354
96. Cesarman E., Mesri E.A., and Gershengorn M.C. Viral G protein-coupled receptor and Kaposi's sarcoma. A model of paracrine neoplasia?. J Exp Med 191 (2000) 417-422
97. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E.G., Gutkind J.S., et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391 (1998) 86-89
98. Sodhi A., Montaner S., and Gutkind J.S. Does dysregulated expression of a dysregulated viral GPCR trigger Kaposi's sarcomagenesis?. FASEB J 18 (2004) 422-427
99. Cotran A.S., Kumar V., and Collins T. Neoplasia. In: Cotran A.S., Kumar V., and Collins T. (Eds). Robbins pathological basis of disease. 6th ed. (1999), W.B. Saunders Company, New York 260-327
100. Flore O., Rafii S., Ely S., O'Leary J.J., Hyjek E.M., and Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394 (1998) 588-592
101. Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M.C., and Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385 (1997) 347-350
102. Sturzl M., Hohenadl C., Zeitz C., Castanos-Velez E., Wunderlich A., Ascherl G., et al. Expression of K13/vFLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 91 (1999) 1725-1733
103. Guasparri I., Keller S.A., and Cesarman E. KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199 (2004) 993-1003
104. Friborg Jr. J., Kong W., Hottiger M.O., and Nabel G.J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402 (1999) 889-894
105. Radkov S.A., Kellam P., and Boshoff C. The latent nuclear antigen of Kaposi's sarcoma-asociated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene H-ras transforms primary rat cells. Nat Med 6 (2000) 1121-1127
106. Miller C.S. Pleiotropic mechanisms of virus survival and persistence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 (2005) S27-S36
107. An J., Lichtenstein A.K., Brent G., and Retting M.B. The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and AP1 response element. Blood 99 (2002) 649-654
108. An J., Sun Y., Sun R., and Retting M.B. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of NF-kappa B and JNK/AP1 pathways. Oncogene 22 (2003) 3371-3385
109. Muralidhar S., Pumfrery A.M., Hassani M., Sadaie M.R., Azumi M., Kishishita M., et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol 72 (1998) 4980-4988
110. Fiorelli V., Barillari G., Toschi E., Sgadari C., Monini P., Sturzl M., et al. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to HIV tat protein: implication for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 162 (1999) 1165-1170
111. Yen-Moore A., Hudnall S.D., Rady P.L., Wagner Jr. R.F., Moore T.O., Memar O., et al. Differential expression of HHV-8 VGCR cellular homolog gene in AIDS-associated and classic Kaposi's sarcoma: potential role of HIV-1 tat. Virology 267 (2000) 247-251
112. Albini A., Soldi R., Giunciuglio D., Giraudo E., Benelli R., Primo L., et al. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med 2 (1996) 1371-1375
113. Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S., Manzari V., et al. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha 5 beta 1 and alpa V beta 3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 94 (1999) 663-672
114. Barillari G., Sgadari C., Palladino C., Gendelman R., Caputo A., Morris C.B., et al. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's Sarcoma via induction of basic fibroblast growth factor and alpha V beta 3 integrins. J Immunol 163 (1999) 1929-1935
115. Hase T., Kawashiri S., Tanak A., Nazaki S., Noguchi N., Kato K., et al. Correlation of basic fibreblast growth factor expression with the invasion and the prognosis of oral squamous cell carcinoma. J Oral Pathol Med 35 (2006) 136-139
116. Aoki Y., Jaff E.S., Chang Y., Jones K., Teruya-Feldstein J., Moore P.S., et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesviruses-encoded interleukin-6. Blood 93 (1999) 4034-4043
117. Mesri E.A. Inflammatory reactivation and angiogenecity of Kaposi's sarcoma-associated herpesvirus/HHV8: a missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Blood 93 (1999) 4031-4033
118. Vogelstein B., and Kinzler K.W. The multistep nature of cancer. Trends Genet 9 (1993) 138-141
119. Morin P., Trent J.M., Collins F.S., and Vogelstein B. Cancer genetics. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 447-453
120. Crum C.P. The female genital tract. In: Cotran A.S., Kumar V., and Collins T. (Eds). Robbins pathological basis of disease. 6th ed. (1999), W.B. Saunders Company, New York 1035-1091
121. Reichman R.C. Human papillomavirus infections. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 1056-1058
122. Young R.C. Gynecologic malignancies. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 553-558
123. Knowles D.M., Cesarman E., Chadburn A., Frizzera G., Chen J., Rose E.A., et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85 (1995) 552-565
124. Chadburn A., Cesarman E., and Knowles D.M. Molecular pathology of posttransplantation lymphoproliferative disorders. Semin Diagn Pathol 14 (1997) 15-26